NPCENeuroPace, Inc.
$12.91+19% 1Y
$12.91
$9.4052 weeks$19.29
Is the price fair?
What NPCE's price assumes
NeuroPace, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 5.49× revenue.
5.49
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 45.6
Price / book · as of 2026-Q2
- EV / sales
- 5.56
EV / sales
Details›
- Price / bookas of 2026-Q2
- 45.6
- EV / EBIToperating margin −15%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q2
- 5.56
- Market capitalisation34.3 million shares, counted Aug 7, 2026
- $443M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.